Package Leaflet: Information for the User
Betahistina Tarbis 24 mg Tablets EFG
Betahistina Dihydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Betahistina Tarbis contains betahistina. This medicine is called a “histamine analogue”.
Betahistina is indicated for the treatment of vertigo, tinnitus, and hearing loss associated with Meniere's syndrome.
This medicine works by improving blood flow in the inner ear. This reduces the accumulation of pressure.
Do not take Betahistina Tarbis
If you are in any of the above situations, do not take this medicine and consult your doctor.
Warnings and precautions
Consult your doctor or pharmacist before taking betahistina:
If any of the above applies to you, consult your doctor or pharmacist before taking betahistina.
Your doctor will tell you if it is safe for you to start taking this medicine.
It is also possible that your doctor may want to monitor your asthma while you are taking betahistina.
Other medicines and Betahistina Tarbis
Tell your doctor or pharmacist if you are using, have recently used, or might use other medicines, including those obtained without a prescription. This includes herbal medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
Using Betahistina Tarbis with food, drinks, and alcohol
You can take this medicine with or without food.
Pregnancy, breast-feeding, and fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take betahistina tablets if you are pregnant unless your doctor decides that it is absolutely necessary. Ask your doctor for advice.
Do not breast-feed when taking betahistina tablets unless your doctor tells you to. It is not known whether betahistina passes into breast milk.
Driving and using machines
Betahistina is unlikely to affect your ability to drive or use tools or machines.
However, remember that the illness for which you are being treated with betahistina (vertigo, tinnitus, and hearing loss associated with Meniere's syndrome) may make you feel dizzy or sick, affecting your ability to drive and use machines.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
How to take Betahistina Tarbis
How much Betahistina Tarbis to take
Always follow the instructions of your doctor because your doctor may adjust your dose.
Initially, 8 to 16 mg three times a day, preferably with meals.
Maintenance doses are generally in the range of 24 to 48 mg per day.
Keep taking your tablets. They may take some time to start working.
Betahistina is not recommended for children under 18 years.
If you stop taking Betahistina Tarbis
Keep taking your tablets until your doctor tells you to stop.
Even when you start to feel better, your doctor may want you to continue taking the tablets for some time to make sure the medicine has worked completely.
If you take more Betahistina Tarbis than you should
If you or someone else takes too much betahistina (overdose), talk to a doctor or go to a hospital straight away. Take the medicine with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service (telephone 91 562 04 20), indicating the medicine and the amount taken.
If you forget to take Betahistina Tarbis
If you forget to take a dose, wait until the next one. Do not try to make up for the missed dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following serious side effects may occur during treatment with Betahistina Tarbis:
Allergic reactions such as:
If you get any of these side effects, stop taking the treatment immediately and talk to your doctor.
Common(may affect up to 1 in 10 people):
Other side effects that have been reported with the use of betahistina
Itching, skin rash, hives, mild stomach upset such as vomiting, stomach pain, and swelling. Taking betahistina with food may help reduce stomach problems.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency website: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after “EXP”. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Betahistina Tarbis
The active substance is betahistina dihydrochloride.
Each tablet contains 24 mg betahistina dihydrochloride equivalent to 15.63 mg betahistina.
The other ingredients are:
Microcrystalline cellulose (E460), mannitol (E421), colloidal anhydrous silica (E551), citric acid (E330), talc (E553b).
Appearance and packaging
Tablet.
Betahistina Tarbis 24 mg Tablets EFG
White to off-white, scored, round, biconvex tablets, engraved with "24 / B" on one face and smooth on the other (diameter of 10 mm and thickness of 4.40 mm).
The score line is only to facilitate breaking and swallowing, but not to divide into equal doses.
Betahistina Tarbis tablets are available in blister packs of 30, 60, 84, 90, and 120 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Tarbis Farma S.L.
Gran Vía Carlos III, 94
08028 Barcelona
Spain
Manufacturer
Amarox Pharma B.V.
Rouboslaan 32
Voorschoten, 2252TR
Netherlands
This medicine is authorised in the Member States of the European Economic Area under the following names:
Netherlands: Betahistine Amarox 24 mg tabletten
Spain: Betahistina Tarbis 24 mg comprimidos EFG
Date of last revision of this leaflet: January 2022
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/